Inventor
Reynald Michael LESCARBEAU
Inventor
US
Overview
Patents· 4 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C12NMicroorganisms or enzymes29%
C07KPeptides14%
PatentTitleYear
12,460,205Compositions and methods for treating alpha-1 antitrypsin deficiency202511,965,165Compositions and methods for TTR gene editing and treating ATTR amyloidosis202411,795,460Compositions and methods for TTR gene editing and treating ATTR amyloidosis202311,549,107Compositions and methods for treating alpha-1 antitrypsin deficiency2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to INTELLIA THERAPEUTICS INC (4)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INTELLIA THERAPEUTICS INC | 4 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 4 | 2023–2025 |